Workflow
监管创新
icon
Search documents
报告显示在线旅游消费维权舆情主要集中在三方面
Sou Hu Cai Jing· 2025-09-27 11:14
本报告通过对2025年在线旅游消费满意度问卷调查数据、2025年1月1日-2025年9月20日在线旅游消费维 权舆情数据等分析总结而来。 第二是大数据杀熟问题和虚假宣传问题,这两类问题主要对消费者的个人信息保护以及知情权、选择权 造成损害。从个人信息保护来看,其满意度得分仅为81.87分,在舆情数据中,大数据杀熟问题比例 77.30%,信息泄露问题比例23.05%;从营销宣传来看,尽管"营销宣传"维度满意度得分相对较高,达 到83.71分,但舆情数据显示虚假宣传比例达到72.90%。这些问题既损害了消费者的合法权益,也削弱 了消费者对在线旅游平台及其提供相关产品和服务的信任,不利于在线旅游行业的规范健康发展。 第三是售后服务问题,其在舆情数据中占比较高且满意度得分相对偏低。"售后服务"维度的满意度得分 为82.58分,在体验维度排名相对靠后。具体来看,退款问题尤为突出,舆情比例高达85.58%,远高于 投诉处理(30.22%)等其他售后问题,需要重点关注。 报告建议,有关部门要加大监管和处罚力度。有关部门应当建立日常检查、定期检查以及与相关部门联 合检查的监督管理制度,对在线旅游经营服务加强日常监督检查,一旦 ...
海南出台药品医疗器械化妆品监管改革实施方案
Hai Nan Ri Bao· 2025-04-30 01:59
Core Viewpoint - The implementation plan for the reform of drug, medical device, and cosmetic regulation in Hainan aims to enhance the competitiveness of the biopharmaceutical industry by introducing 20 reform measures across five key areas [1][2] Group 1: Regulatory Reforms - The plan emphasizes improving the efficiency of review and approval processes, focusing on the actual needs of enterprises during product development and registration [1] - It aims to facilitate the market entry of innovative products, targeting the launch of at least one innovative product annually and the introduction of over 60 licensed medical devices each year [1] Group 2: Innovation in Biopharmaceuticals - The initiative seeks to address bottlenecks in innovation by enhancing clinical research levels and increasing support for traditional Chinese medicine research and development [2] - By the end of 2027, the goal is to promote the registration or filing of over 15 hospital preparations [2] Group 3: International Competitiveness - The plan includes regulatory innovations to enhance product participation in international markets, aiming to create a high ground for real-world research applications [2] - It promotes the "Research and Use + Haikou/Qionghai Production" model to facilitate local production of more innovative drugs and medical devices [2] Group 4: Industry Development - The implementation of the plan is expected to significantly promote structural adjustments, efficiency transformations, and quality improvements in Hainan's biopharmaceutical industry [2] - It aims to create a unique competitive advantage for Hainan's biopharmaceutical sector, contributing to the establishment of a modern industrial system with Hainan characteristics [2]